Navigation Links
Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90,Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory,Breast and Ovarian Cancers at ASCO

es that regulatory filings to support initiation of this clinical trial will be completed by mid-year 2007. Kosan plans to initiate a larger, international Phase 2/3 trial of alvespimycin in combination with trastuzumab in patients with HER2-positive metastatic breast cancer later in 2007.

Kosan also plans to pursue development of alvespimycin as a treatment for patients with acute myeloid leukemia (AML).

Kosan is also testing alvespimycin delivered orally in a Phase 1 dose escalation trial on both daily and every other day schedules. While dose escalation continues in this trial, early results have shown prolonged stable disease in patients with fibrosarcoma, hemangioendothelioma, melanoma and renal cell carcinoma with a favorable side effect profile.

About Kosan

Kosan Biosciences is a biotechnology company advancing two new classes of anticancer agents through clinical development -- Hsp90 (heat shock protein 90) inhibitors and epothilones. Kosan is leveraging its proprietary discovery platform to generate a pipeline of potentially significant product candidates, primarily in the area of oncology.

Hsp90 inhibitors have a novel mechanism of action targeting multiple pathways involved in cancer cell growth and survival. Kosan's proprietary formulation of tanespimycin (KOS-953) is currently in Phase 1 and 2 clinical trials, primarily for multiple myeloma in combination with Velcade(R) (bortezomib) and HER2-positive metastatic breast cancer in combination with Herceptin(R) (trastuzumab). In addition, intravenous and oral formulations of Kosan's second-generation Hsp90 inhibitor, alvespimycin (KOS-1022), are being evaluated in Phase 1 clinical trials.

Epothilones inhibit cell division with a mechanism of action similar to taxanes, one of the most successful classes of anti-tumor agents. KOS-1584 is in Phase 1 clinical trials in patients with solid tumors. Kosan's epothilone program is partnered with Roche through a global devel
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO
2. Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO
3. Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO
4. Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
5. Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR
6. Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR
7. Kosan Announces Data Presentations at Upcoming AACR Annual Meeting
8. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
9. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
10. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
11. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
Post Your Comments:
(Date:6/19/2013)... , June 19, 2013   Life ... announces a licensing agreement granting Suzhou Ribo Life ... manufacture siRNA therapeutics in China ... will formulate proprietary siRNA molecules in combination with ... to address human diseases with high unmet medical ...
(Date:6/19/2013)... , 19. Juni 2013 /PRNewswire/ ... dass mit der Entwicklung von SCS ... Schritt in der Beschichtung mit Parylene ... Vorteile von biokompatiblem Parylene mit antimikrobiellen ... Beseitigung schädlicher Mikroorganismen auf beschichteten medizinischen ...
(Date:6/18/2013)... -- Intercept Pharmaceuticals, Inc.  (NASDAQ: ICPT ), a ... commercialization of novel bile acid therapeutics to treat chronic ... public offering of 1,730,000 shares of its common stock ... In addition, Intercept has granted the underwriters a 30-day ... of common stock. All of the shares ...
Breaking Medicine Technology:Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2
(Date:6/19/2013)... (PRWEB) June 19, 2013 Fit Body ... Laing recently held a charity boot camp in order to ... The fitness boot camp franchise hosted the Brent ... 11 a.m. with 75 boot camp participants and collected over ... boot camp marks the second fundraiser held for Orlando local ...
(Date:6/19/2013)... North American Seminars combines a ... with an online continuing education course directed ... therapists. , The two day live ... online continuing education course will provide ... skills needed to evaluate and treat dizziness and ...
(Date:6/19/2013)... 19, 2013 Blueforce Development Corporation, ... machine software, today announced it has been awarded ... Fusion Engine technology. The award coincides with ... of key strategic partnerships. , Blueforce Development ... and machine-to-machine (M2M) software products that support the ...
(Date:6/19/2013)... June 19, 2013 The reason for the ... because users can place a 4x8 flood tray inside the ... to work around. In addition, Gorilla Grow Tents are ... are the tallest, thickest and strongest grow tents on the ... grow tent standards. , Gorilla Grow Tents are ...
(Date:6/19/2013)... Tornadoes and their devastating aftermath have increased ... fallen victim to these deadly storms find it hard ... protected families and corporations from natural and man-made disasters ... in the philosophy of providing a storm shelter that ... people to stand up, with light and a battery-operated ...
Breaking Medicine News(10 mins):Health News:Fit Body Boot Camp in Orlando Held Successful “Brent Can Breathe” Charity Boot Camp with Proceeds Going to Support Orlando Local Brent Snyder with Cystic Fibrosis 2Health News:New Evidence Based Information on Treatment for Over 8 Million People in the U.S. Affected With Disorders of the Vestibular System 2Health News:Blueforce Awarded Patent for Decentralized Sensor Fusion 2Health News:Stealth Grow Tent Brand’s Popularity Rises 2Health News:Radius Engineering International Inc. Tornado-Resistant Storm Shelters 2
... spread of lung infections, including pandemic strains , , FRIDAY, Jan. ... dampen part of the body,s immune response so infections can ... person to perish, a new study says. , The compound ... mice, helped mitigate the cytokine response, a common immune reaction ...
... FRANCISCO, Calif., Jan. 23 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ... conference on Multiple Sclerosis taking,place this week in Santa Fe, New ... 25, 2009 , Time: 2:30 - ... Therapeutic Approaches to MS , Presentation ...
... source of information on scleroderma and the financial help available for ... ... 2009 -- NeedyMeds, a national nonprofit, adds a new resource page ... scleroderma-specific source of help for those looking for information on the ...
... enters the future and endures the tough economy through the guidance of ... attended annual convention hosted by the SPCP. This year the convention and ... ... Des Plaines, IL (PRWEB) January 23, 2009 -- Permanent Makeup enters the ...
... highlight the dangers of infection from live birds, report ... peanut butter contaminated with salmonella has dominated the headlines ... is also prevalent in live poultry. , The Jan. ... and Prevention,s Morbidity and Mortality Weekly Report ...
... DIEGO, Jan. 22 SeQual Technologies Inc., a ... worldwide for their reliability, quality, and revolutionary design ... Release (AWR) from the U.S. Army,s Research, Development, ... 1000A. The certification indicates that the Eclipse(R) Oxygen ...
Cached Medicine News:Health News:Drug Impedes Body's Deadly Reaction to Flu Virus 2Health News:New Source of Information on Scleroderma Medications 2Health News:New Source of Information on Scleroderma Medications 3Health News:Society of Permanent Cosmetic Professionals (SPCP) Hosts 18th Annual Convention in Las Vegas 2Health News:Society of Permanent Cosmetic Professionals (SPCP) Hosts 18th Annual Convention in Las Vegas 3Health News:Society of Permanent Cosmetic Professionals (SPCP) Hosts 18th Annual Convention in Las Vegas 4Health News:Salmonella Common In U.S. Poultry 2Health News:Salmonella Common In U.S. Poultry 3Health News:SeQual Technologies is Awarded the U.S. Army Airworthiness Certification 2
Fenestrated 14 mm blades. Wide extension of blade for protection of lids. Self-locking mechanism. Dull finish....
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Infant model. Blades: 7 mm. Solid blades with locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
Medicine Products: